Sunday, March 13, 2011

CD57: A Marker for ARVs?

CFS Central:

One of the biggest problems in monitoring ME/CFS patients on antiretroviral therapy is the lack of markers to evaluate the drugs’ effects on the immune system.

For patients on medications to treat diseases like HIV and hepatitis, often their immune markers improve and the viral loads decrease well before the patients feel better.

This phenomenon is particularly common in patients with longstanding illness. However, ... Read more>>

No comments:


Related Posts with Thumbnails